The Pharmacokinetics of Dolutegravir, Darunavir/Cobocistat When Co-administered in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 28 May 2018
At a glance
- Drugs Cobicistat/darunavir (Primary) ; Dolutegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 20 May 2018 Status changed from active, no longer recruiting to completed.
- 07 Mar 2018 Results presented at the 25th Conference on Retroviruses and Opportunistic Infections
- 27 Oct 2017 Planned End Date changed from 1 Feb 2018 to 1 Aug 2018.